Cusack GroupCollaborations

Stephen Cusack

• Rig-I
  D. Kolakofsky, University of Geneva, Switzerland
  D. Gerlier, INSERM, Lyon, France

• Leucyl-tRNA synthetase
  S. Martinis, University of Illinois, Urbana, USA

• Influenza polymerase
  R. Ruigrok, University of Grenoble, France
  J. Ortin, CSIC, Madrid, Spain
  Nadia Naffakh, Pasteur Institute Paris, France
  J.Briggs, EMBL Heidelberg, Germany

• Influenza anti-viral drug design
  O. Szolar, Savira Pharmaceuticals, Vienna, Austria
  Klaus Klumpp, Roche, USA

• Antibiotics targeting leucyl-tRNA synthetase
  D. Alley, Anacor pharamaceuticals, Palo Alto, USA

• Dosage Compensation Complex
  A. Akhtar, MPI, Freiburg, Germany

• CBC, ARS2
  E. Bertrand, CNRS Montpellier, France

• La Crosse Virus polymerase
  F. Weber, University of Marburg, Germany